
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.680 | 1.310 | 0.630 |
Shares | 99.340 | 99.340 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 13.518 | 17.149 |
Price to Book | 2.223 | 3.717 |
Price to Sales | 3.586 | 5.028 |
Price to Cash Flow | 7.551 | 14.632 |
Dividend Yield | 0.377 | 0.520 |
5 Years Earnings Growth | 1.716 | 8.646 |
Number of long holdings: 33
Number of short holdings: 21
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Ionis Pharma | US4622221004 | 10.50 | 43.03 | +0.12% | |
Biogen | US09062X1037 | 9.49 | 131.95 | +3.09% | |
Crispr Therapeutics | CH0334081137 | 5.17 | 56.09 | -0.30% | |
Exelixis | US30161Q1040 | 5.06 | 37.26 | +2.87% | |
Alnylam | US02043Q1076 | 5.02 | 401.80 | +2.44% | |
Gilead | US3755581036 | 4.96 | 113.18 | +0.79% | |
Bavarian Nordic | DK0015998017 | 4.61 | 235.6 | -0.80% | |
Regeneron Pharma | US75886F1075 | 4.55 | 558.87 | +2.46% | |
Amgen | US0311621009 | 4.49 | 296.88 | +0.58% | |
Jazz Pharma | IE00B4Q5ZN47 | 4.45 | 115.52 | +0.78% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Selectra J Lamarck Biotech Class A | 70.05M | -6.50 | -9.97 | 0.93 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review